Skip to main content
Premium Trial:

Request an Annual Quote

RevoluGen, GE Healthcare Life Sciences Ink DNA Extraction Product Manufacturing Deal

NEW YORK — UK reagent firm RevoluGen said on Monday that it has signed a global manufacturing deal for its Fire Monkey/Fire Flower high molecular weight DNA extraction and purification product with GE Healthcare Life Sciences.

The Fire Monkey/Fire Flower uses spin columns to extract high molecular weight DNA with an average length of 100 kb or more from animal and bacterial cells, followed by the removal of DNA fragments smaller than 10 kb.

Under the terms of the deal, GE Healthcare Life Sciences will non-exclusively manufacture the product for RevoluGen. Additional terms were not disclosed.

"With this manufacturing agreement we will be able to ensure a high-quality supply of our world-leading Fire Monkey/Fire Flower product from a source sufficiently flexible to be able to cope with any global scale up in demand," RevoluGen CEO Pieter Haitsma Mulier said in a statement.

In mid-2019, RevoluGen signed on Merck KGaA as a non-exclusive global distributor of the Fire Monkey/Fire Flower product.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.